Russia will sell 100 million doses of its highly touted coronavirus vaccine to India once final trials and regulatory steps are completed, Russia’s sovereign fund that is bankrolling the project announced Wednesday.
India is one of at least 32 countries that have expressed interest in testing and obtaining Russia’s Sputnik V vaccine. Brazil, Mexico and Kazakhstan have signed supply deals with Russia so far.
The Russian Direct Investment Fund (RDIF) said it has partnered with the Hyderabad-based global pharmaceutical company Dr. Reddy’s on clinical trials and distribution of Sputnik V in India.
“Upon regulatory approval in India, RDIF shall supply to Dr. Reddy’s 100 million doses of the vaccine,” it said in a statement on its website.
“Deliveries could potentially begin in late 2020 subject to completion of successful trials and registration of the vaccine by regulatory authorities in India,” RDIF added.
RDIF has a manufacturing partnership agreement to make 300 million doses of the Russian adenovirus-based vector vaccine, which is administered in two shots, in India.
Russia began post-registration Phase 3 trials of Sputnik V among 40,000 volunteers in Moscow earlier this month amid questions surrounding its long-term safety. First results are expected either next month or in November, RDIF said.
India's confirmed Covid-19 cases soared past 5 million Wednesday. The last million infections were reported in the country of 1.3 billion over the past 11 days, with global health officials warning that India is “not even in the middle” of its outbreak.
A Message from The Moscow Times:
Dear readers,
We are facing unprecedented challenges. Russia's Prosecutor General's Office has designated The Moscow Times as an "undesirable" organization, criminalizing our work and putting our staff at risk of prosecution. This follows our earlier unjust labeling as a "foreign agent."
These actions are direct attempts to silence independent journalism in Russia. The authorities claim our work "discredits the decisions of the Russian leadership." We see things differently: we strive to provide accurate, unbiased reporting on Russia.
We, the journalists of The Moscow Times, refuse to be silenced. But to continue our work, we need your help.
Your support, no matter how small, makes a world of difference. If you can, please support us monthly starting from just $2. It's quick to set up, and every contribution makes a significant impact.
By supporting The Moscow Times, you're defending open, independent journalism in the face of repression. Thank you for standing with us.
Remind me later.
